Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Theravance Biopharma, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 119 | 128 | +9 |
| Shares | 45.8M | 44.9M | −877.0K (−1.9%) |
| Value | $368.9M | $422.4M | +$53.5M (+14.5%) |
New holders (24)
Institutions that held Theravance Biopharma, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (15)
Institutions that held Theravance Biopharma, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Pictet Asset Management Holding SA | 684,892 | $5.55M |
| Algert Global LLC | 105,609 | $851.2K |
| Royce & Associates LP | 59,009 | $475.6K |
| Prudential Financial Inc | 57,240 | $461.4K |
| ExodusPoint Capital Management, LP | 38,018 | $306.0K |
| Sherbrooke Park Advisers LLC | 34,746 | $280.1K |
| Y-Intercept (Hong Kong) Ltd | 31,194 | $251.4K |
| Verition Fund Management LLC | 12,642 | $101.9K |
| Brevan Howard Capital Management LP | 11,093 | $89.4K |
| Quantbot Technologies LP | 7,396 | $59.6K |
| Allspring Global Investments Holdings, LLC | 521 | $4.20K |
| Simplex Trading, LLC | 323 | $2.00K |
| SRS Capital Advisors, Inc. | 57 | $460 |
| Capital Performance Advisors LLP | 5 | $40 |
| Covestor Ltd | 31 | $0 |